(Total Views: 796)
Posted On: 07/21/2020 8:51:41 AM
Post# of 148902
Re: invisioner #44152
We don't know for sure. The PR just states one died from the total group of participants not the treatment or placebo arm. This was however enough for low-life AF to base another slanderous article on in STAT. This guy is disgusting and needs to be held to account. Look at how he twists reality here for his benefit:
"CytoDyn released safety data on its experimental drug for Covid-19 on Tuesday, but efficacy data were conspicuously absent, and the company disclosed that a patient had died following treatment with the therapy."
From the PR:
"Of the 84 patients treated, one patient died 33 days after enrollment due to an event unrelated to leronlimab."
"CytoDyn released safety data on its experimental drug for Covid-19 on Tuesday, but efficacy data were conspicuously absent, and the company disclosed that a patient had died following treatment with the therapy."
From the PR:
"Of the 84 patients treated, one patient died 33 days after enrollment due to an event unrelated to leronlimab."
(1)
(0)Scroll down for more posts ▼
